P ulmonary hypertension is mediated to a large extent by plexogenic pulmonary arteriopathy. The dominant features of this arteriopathy include 1) sustained pulmonary vasoconstriction, 2) pulmonary arterial medial hypertrophy and muscularization of distal vessels due to smooth muscle cell hyperplasia and hypertrophy, and 3) obliterative intimal lesions in which smooth muscle cells predominate. Therefore, identifying the factors involved in triggering pulmonary vasoconstriction and promoting pulmonary artery smooth muscle cell (PASMC) proliferation is an area of active investigation. Pulmonary vascular tone and PASMC proliferation are both regulated by intracellular Ca 2+ (6, 12, 14, 17, 20) . An increase in cytoplasmic free Ca 2+ concentration ([Ca 2+ ] cyt ) in PASMC induces both contraction and proliferation, thereby uniting the two fundamental derangements (pulmonary vasoconstriction and vascular medial hypertrophy) underlying severe pulmonary hypertension.
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Vasoactive and mitogenic agonists trigger Ca 2+ mobilization by activating inositol 1,4,5-trisphosphate (IP 3 ) receptors in the sarcoplasmic reticulum (SR) membrane, leading to SR Ca 2+ release and subsequent depletion. This internal Ca 2+ store depletion triggers a sustained Ca 2+ influx known as capacitative Ca 2+ entry (CCE). The two major functions of CCE are to refill the SR Ca 2+ stores and to maintain adequate Ca 2+ levels in the cytosol and nucleus in the face of high levels of mitogenic stimulation. The Ca 2+ elevation associated with CCE occurs via activity of a special family of Ca 2+ channels known as the store-operated Ca 2+ channels (SOCs). These channels consist of hetero-or homotetrameric subunits encoded by the transient receptor potential (TRP) genes (19) . Expression of TRP genes, function of SOCs, and amplitude of CCE are all involved in the regulation of pulmonary vascular tone and PASMC growth under physiological conditions (6, 17, 20) . Furthermore, in PASMC isolated from patients with primary pulmonary hypertension (PPH), CCE is enhanced and TRP genes are upregulated, suggesting that increased expression of the SOC responsible for CCE may play an important role in the pathophysiology of PPH (6) . This review focuses on the role of Ca 2+ in PASMC proliferation, highlighting the importance of CCE, mediated by SOC and TRP gene expression, in maintaining the adequate intracellular Ca 2+ required to stimulate and maintain proliferation.
Role of Ca 2+ in cell proliferation
Intracellular Ca 2+ is a critical second messenger responsible for linking external stimuli to contraction, proliferation, and gene expression. Mitogenic stimulation leads to a rise in [Ca 2+ ] cyt due to Ca 2+ release from internal stores and Ca
2+
influx through sarcolemmal Ca 2+ channels. A rise in [Ca 2+ ] cyt is transmitted by passive diffusion through nuclear pores in the nuclear envelope, thus increasing nuclear Ca 2+ concentration ([Ca 2+ ] n ) (8) -CaM-dependent kinases (e.g., CaM kinase IV) that promote phosphorylation of proteins, such as Ca 2+ /cAMP response element (CRE) binding protein (CREB, a nuclear Ca 2+ -responsive transcription factor) and Ras (a cytosolic Ca 2+ -responsive transcription factor), that are required for initiating and maintaining the cell cycle. In the cell cycle, the transition from G 0 to G 1 phase (i.e., from the resting state to the initiation of DNA synthesis), transition from G 1 to S phase (i.e., to the replication of nuclear DNA), and transition from G 2 to M (mitosis) phase as well as the entire mitosis phase are dependent on the activated Ca 2+ -CaM complex (1). Beyond signal transduction, an adequate level of Ca 2+ in intracellular stores, such as the SR, is crucial for normal cellular functions, including posttranslational modifications (e.g., correct folding, assembly, and glycosylation) of recombinant proteins. Therefore, maintenance of a high Ca 2+ concentration in the SR ([Ca   2+ ] SR ) also plays a critical role in optimizing protein and lipid synthesis and sorting. When the SR Ca 2+ is depleted, the resultant disturbance of posttranslational modification of proteins may result in problematic protein trafficking, SR stress (3), growth arrest (15) , and apoptosis (9) . Indeed, removal of external Ca 2+ and/or depletion of stored Ca 2+ have been shown to induce growth arrest in vascular smooth muscle cells (6, 15) . and/or in [Ca 2+ ] n , is the second messenger responsible for linking external mitogenic stimulus to gene expression in vascular smooth muscle cells. Expression of the immediate early genes that encode transcription factors like c-Fos and c-Jun, and of cell cycle regulators like cyclin A and E, can be stimulated by intracellular Ca 2+ because the promoters of these genes contain the CRE (7, 8, 18) . There are many Ca 2+ -sensitive transcription factors (e.g., c-Fos/c-Jun, Ras, cyclin A/B, CREB, proline-rich tyrosine kinase 2, NF-NB) and signal transduction proteins (e.g., CREB kinase, CaM kinase IV, MAPK-activated protein kinase 2) that are involved in cell growth and proliferation (7, 8) .
The ] cyt activates c-fos transcription via serum response element, whereas a rise in [Ca 2+ ] n activates c-fos transcription via CRE (7, 8 Figure 2 illustrates an example of how CCE is induced in PASMC by passive and active depletion of Ca 2+ from the SR. As shown in Fig. 2A , CCE in PASMC can be observed as a rise in [Ca 2+ ] cyt occurring after passive store depletion with CPA. In the absence of extracellular Ca 2+ (Fig. 2Aa) , CPA, by blocking Ca 2+ sequestration into the SR, induces a transient rise in [Ca 2+ ] cyt due to leakage of Ca 2+ from the SR to the cytoplasm (Fig. 2Ab) (Fig. 2Ah) . Active store depletion by agonist-mediated production of IP 3 and release of Ca 2+ from the SR through IP 3 receptors also triggers CCE. Figure 2B shows an example of how CCE can be induced by active store depletion and how CCE contributes to agonist-mediated vasoconstriction in an isolated rat pulmonary artery ring. In the absence of external Ca 2+ , PA rings exposed to the D-adrenergic receptor agonist phenylephrine (PE) demonstrate a short (46 min) and transient contraction, due presumably to IP 3 -mediated Ca 2+ release. The contraction induced by Ca 2+ release is spontaneously terminated when intracellular stores are depleted and cytosolic Ca 2+ is extruded. Under these conditions, application of the D-receptor blocker phentolamine (Phen, 1 PM) and the VDCC blocker verapamil (Vp, 0.5 PM) closes both ROCs (indirectly by interfering with the receptor) and VDCC. Restoration of extracellular Ca 2+ in the presence of Phen and Vp gives rise to a sustained contraction due to CCE. In this experiment, CCE is triggered by PE-induced active store depletion (Fig. 2B) . The CCEmediated contraction is sensitive to Ni 2+ and La 3+ but is not sensitive to Vp and nifedipine, highlighting its dependence on SOC activity (12) .
Activity of SOCs is the major determinant of the amplitude of CCE, which, in turn, governs the magnitude of CCE-mediated contraction. The cation currents through store depletionactivated SOCs can be recorded by using patch clamp techniques in single PASMC (Fig. 2C) . To record SOC currents ) and anion (Cl ) channels. Whole cell currents are elicited by 300-ms voltage steps from 120 to 0 mV before and after application of CPA (Fig. 2Ca) or PE (Fig. 2Cb) , which either passively or actively depletes Ca 2+ from the SR within 10 min (see Fig. 2, A and B) . Subtraction of the current recorded under control conditions from the current recorded during application of CPA or PE reveals that I SOC is activated by either active or passive depletion of Ca 2+ (Fig. 2C) . Blockade of SOC with Ni 2+ or La 3+ reversibly reduces the amplitudes of I SOC (Fig. 2C) and CCE ( Fig. 2A) (6) and significantly inhibits CCE-mediated pulmonary vasoconstriction (12) and PASMC proliferation (6, 17, 20) .
Together, these observations indicate that CCE can be induced by both active and passive depletion of stored Ca 2+ in the SR. The increase in [Ca 2+ ] cyt due to CCE is a critical signal transduction element involved in smooth muscle contraction and PASMC proliferation.
CCE is enhanced in PASMC during proliferation
Removal or chelation of extracellular Ca 2+ inhibits PASMC growth in the presence of serum and growth factors (6, 15) , suggesting that a constant Ca 2+ influx is required for PASMC proliferation. Passive depletion of SR Ca 2+ stores with CPA or thapsigargin further inhibits PASMC growth (6, 12, 15, 17, 20) . The synergistically inhibitory effects of chelation of extracellular Ca 2+ and depletion of stored Ca 2+ in the SR on PASMC growth highlight the importance of both Ca 2+ influx and adequate internal Ca 2+ stores in PASMC proliferation. When PASMC are growth arrested by incubation in a serumfree and growth factor-free medium, both the basal level of resting [Ca 2+ ] cyt (Fig. 3, A and Ba) and CPA-mediated CCE amplitude (Fig. 3, A and Bb) are much lower than in proliferating cells cultured in a medium containing 5% fetal bovine serum and growth factors. The rise in [Ca 2+ ] cyt due to CPA-mediated CCE is approximately threefold greater in proliferating PASMC than in growth-arrested cells and is insensitive to VDCC blockers and sensitive to the SOC blockers Ni 2+ and SKF-96365 (see Fig. 2A ) (6) . Furthermore, the CPA-mediated transient increase in [Ca 2+ ] cyt in the absence of extracellular Ca 2+ (which is mainly due to Ca 2+ leakage from the SR to the cytoplasm, and its amplitude partially reflects [Ca 2+ ] SR ) is approximately twofold greater in proliferating cells than in growth-arrested (or quiescent) PASMC. This indicates that Ca 2+ concentration in the SR is also increased in proliferating PASMC (Fig. 3C) . In addition to the fluorescence microscopy results, electrophysiological data also show that I SOC , induced by passive store depletion with CPA, is significantly increased in proliferating PASMC compared with growth-arrested cells (6) .
Together, these data suggest that mitogen-induced PASMC proliferation requires elevated Ca 2+ concentrations in the cytoplasm, nucleus, and SR. ] SR , and attenuates PASMC proliferation (6, 17, 20) .
The mechanism behind the enhanced CCE seen in proliferating PASMC likely involves upregulation of the genes responsible for encoding SOC (e.g., TRP genes). Exposure of PASMC , despite the presence of the D-receptor blocker phentolamine (Phen, 1 PM) and the VDCC blocker verapamil (Vp, 0.5 PM), gives rise to a sustained contraction due to CCE triggered by PE-induced active store depletion. C: whole cell SOC currents (I SOC ) in PASMC induced by passive and active store depletion in PASMC. Cells were superfused with solutions containing 120 mM Na + and 20 mM Ca 2+ as charge carrier and were dialyzed with solutions containing 138 mM Cs + (to eliminate K + currents) and ~100 nM free Ca
2+
. The holding potential was set at 0 mV to inactivate voltage-gated cation (e.g., Na + and Ca to growth factors or mitogenic agonists activates tyrosine kinase-coupled receptors (e.g., PDGF receptor). The subsequent phosphorylation and activation of signal transduction proteins (e.g., protein kinases) and transcription factors (e.g.,signal transducer and activator of transcription, c-Jun) lead to upregulated TRP gene expression, increased SOC number, and, ultimately, enhanced CCE (Fig. 4) (20) .
The molecular identity of SOC in PASMC
The molecular identity of SOC has not been completely elucidated. Work in this area has focused on TRP gene-encoded proteins on the basis of observations that expression of TRP genes in a heterologous transfection system leads to the formation of Ca 2+ -permeable channels activated by receptor activation and store depletion (19) . Each TRP-encoded subunit contains six transmembrane domains (S1S6) with a poreforming loop between S5 and S6. Both NH 2 and COOH terminals are located intracellularly (19) .
The mammalian TRP family can be divided into three subfamilies: 1) TRP-canonical (TRPC) family (or short TRP channels), which is comprised of seven members, TRPC17; 2) TRP-vanilloid (TRPV) family (or Osm-9-like TRP channels), which consists of six members, TRPV16; and 3) TRP-melastatin (TRPM) family (or long TRP chanels), which contains eight members, TRPM18. There are three or more ankyrin domains in the NH 2 -terminal cytosolic region of the short (TRPC) and Osm-9-like (TRPV) TRP channels and a prolinerich motif in the cytosolic COOH-terminal region in the vicinity of S6 of the short and long (TRPM) TRP channels. It has been shown that native SOCs are mainly heterotetramers comprised of different TRP isoforms. Sensitivity to store depletion may be mediated by the cytosolic COOH-terminal tail connected to the S6 transmembrane domain, but the mecha- nism linking store depletion to SOC activation is still unclear (19) . The greatest homology between the subfamilies is seen in the S6 transmembrane domain, and the greatest variance is found in the COOH terminus. The subfamily members differ in their distribution throughout the body as well as in their mode of regulation.
Several human TRP homologs have been identified, including TRPC1, TRPC3, TRPC4, and TRPC6 in human lung tissues and pulmonary vascular smooth muscle and endothelial cells. The human TRP proteins likely encode ROCs as well as SOCs. Data from different cell types as well as experiments involving overexpression of specific TRP proteins have yielded conflicting results in attempting to correlate specific TRP isoforms with SOC properties. This may be explained by the heterotetrameric structure of the TRP channels. For example, a channel made up of two TRPC1, a TRPC3, and a TRPC6 protein may form a functional SOC activated by store depletion, whereas a channel made of two TRPC3 and two TRPC6 proteins may form a functional ROC activated predominantly by receptor-activated G proteins or diacylglycerol. By examining the gating property of overexpressed mammalian TRPC channels, numerous reports demonstrate that TRPC1, TRPC2, TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7 are activated in response to store depletion with SERCA inhibitors (e.g., thapsigargin, CPA) or ionophores (e.g., ionomycin). However, equally numerous reports indicate that TRPC channels overexpressed in mammalian cells are activated by PLC-coupled receptors and are not activated by store depletion (19) . Therefore, the functional link between specific TRP gene products and agonist-mediated Ca 2+ entry (e.g., CCE or receptor-mediated Ca 2+ entry) remains an area for further study.
Upregulated TRPC expression in human PASMC during proliferation
Human TRPC1 is widely distributed throughout the body, whereas TRPC6 is highly expressed in lung tissues and pulmonary arteries. Overexpression of TRPC6 in mammalian cells has been shown to enhance agonist-induced Ca 2+ entry (10) . Inhibition of TRPC6 expression with antisense oligonucleotides has been shown to inhibit agonist-mediated vascular tone in some experimental models (16) . In proliferating human PASMC, TRPC1 and TRPC6 mRNA and protein expression are upregulated and the amplitude of I SOC and CCE (induced by passive store depletion) are both enhanced. The increased mRNA expression of TRPC1 precedes the increase in cell number. Inhibition of either TRPC1 or TRPC6 gene expression with antisense oligonucleotides decreases CCE and attenuates PASMC proliferation (6, 17, 20) . These data suggest that TRPC1 and TRPC6 may be involved in forming native SOCs responsible for CCE in human PASMC and, furthermore, that enhanced TRPC expression and CCE are a prerequisite for human PASMC proliferation.
In attempts to understand the mechanisms involved in the enhanced TRPC gene expression, I SOC , and CCE seen in proliferating PASMC, we examined the role of STAT3 and c-Jun in rat PASMC proliferation (20) . The tyrosine-phosphorylated STAT3 is a downstream signal transduction protein that is acti- (Fig. 4) (20) .
Upregulated TRPC expression and enhanced CCE in PASMC contribute to the development of PPH
As well as its essential role in normal PASMC proliferation, increased CCE, secondary to increased formation of SOCs by upregulated TRP genes, may be important in the development of pulmonary vascular remodeling in patients with PPH. Using PASMC isolated from patients undergoing lung transplant for PPH and secondary pulmonary hypertension (SPH), our laboratory has been able to compare the magnitude of CCE between PPH-PASMC and SPH-PASMC. When matched for pulmonary arterial pressure and pulmonary vascular resistance, growth-arrested PASMC from PPH patients demonstrate significantly higher resting [Ca 2+ ] cyt compared with cells from SPH patients. In addition, the magnitude of CCE, evoked by passive store depletion with CPA, is significantly greater in PASMC from PPH patients than in cells from SPH patients (6) . At a molecular level, PPH is a heterogeneous disorder, with abnormal PASMC proliferation as its central theme. These data suggest that enhanced CCE, secondary to upregulated TRP genes, may be important in the pathogenesis of vascular remodeling in severe pulmonary hypertension and/or PPH. Accordingly, interruption of CCE at any point, from agents that downregulate TRPC gene expression to specific blockers for SOCs in PASMC, may prove beneficial in the development of therapeutic approaches for treatment of severe pulmonary hypertension. ] n needs to be maintained by 1) increasing the number of functional Ca 2+ channels in the plasma membrane, 2) enhancing the function of existing Ca 2+ channels, and 3) maintaining the signal transduction between emptied SR and the plasmalemmal permeability to Ca 2+ . The TRPC family is a unique group of cation channels that are opened by both receptor activation and store depletion. Upregulation and functional enhancement of these channels have been implicated in both normal PASMC proliferation and in pulmonary vascular medial hypertrophy in patients with pulmonary arterial hypertension. Better defining the events involved in TRPC gene expression, SOC activation, and CCE regulation could lead to the development of new therapeutic approaches for abnormal PASMC proliferation in patients with severe pulmonary hypertension.
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